The Beneficial Effects of n-3 Polyunsaturated Fatty Acids on Diet Induced Obesity and Impaired Glucose Control Do Not Require Gpr120

GPR120 (Ffar4) has been postulated to represent an important receptor mediating the improved metabolic profile seen upon ingestion of a diet enriched in polyunsaturated fatty acids (PUFAs). GPR120 is highly expressed in the digestive system, adipose tissue, lung and macrophages and also present in the endocrine pancreas. A new Gpr120 deficient mouse model on pure C57bl/6N background was developed to investigate the importance of the receptor for long-term feeding with a diet enriched with fish oil. Male Gpr120 deficient mice were fed two different high fat diets (HFDs) for 18 weeks. The diets contained lipids that were mainly saturated (SAT) or mainly n-3 polyunsaturated fatty acids (PUFA). Body composition, as well as glucose, lipid and energy metabolism, was studied. As expected, wild type mice fed the PUFA HFD gained less body weight and had lower body fat mass, hepatic lipid levels, plasma cholesterol and insulin levels and better glucose tolerance as compared to those fed the SAT HFD. Gpr120 deficient mice showed a similar improvement on the PUFA HFD as was observed for wild type mice. If anything, the Gpr120 deficient mice responded better to the PUFA HFD as compared to wild type mice with respect to liver fat content, plasma glucose levels and islet morphology. Gpr120 deficient animals were found to have similar energy, glucose and lipid metabolism when fed HFD PUFA compared to wild type mice. Therefore, GPR120 appears to be dispensable for the improved metabolic profile associated with intake of a diet enriched in n-3 PUFA fatty acids.

[1]  D. Polidori,et al.  Alteration of the Glucagon Axis in GPR120 (FFAR4) Knockout Mice , 2014, The Journal of Biological Chemistry.

[2]  N. Morgan,et al.  GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans , 2014, Diabetologia.

[3]  K. Nasir,et al.  Omega-3 Fatty Acid Blood Levels: Clinical Significance and Controversy , 2013, Circulation.

[4]  P. Flachs,et al.  Stimulation of mitochondrial oxidative capacity in white fat independent of UCP1: a key to lean phenotype. , 2013, Biochimica et biophysica acta.

[5]  M. Yorek,et al.  Modification of high saturated fat diet with n‐3 polyunsaturated fat improves glucose intolerance and vascular dysfunction , 2013, Diabetes, obesity & metabolism.

[6]  P. Flachs,et al.  Anti-obesity effect of n-3 polyunsaturated fatty acids in mice fed high-fat diet is independent of cold-induced thermogenesis. , 2013, Physiological research.

[7]  Eun-Hee Kim,et al.  Endogenously synthesized n-3 polyunsaturated fatty acids in fat-1 mice ameliorate high-fat diet-induced non-alcoholic fatty liver disease. , 2012, Biochemical pharmacology.

[8]  J. Mclaughlin,et al.  Duodenal Enteroendocrine I-Cells Contain mRNA Transcripts Encoding Key Endocannabinoid and Fatty Acid Receptors , 2012, PloS one.

[9]  Lars Löfgren,et al.  The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma[S] , 2012, Journal of Lipid Research.

[10]  F. Duca,et al.  Increased Oral Detection, but Decreased Intestinal Signaling for Fats in Mice Lacking Gut Microbiota , 2012, PloS one.

[11]  K. Verhoeckx,et al.  Metabolic Effects of n-3 PUFA as Phospholipids Are Superior to Triglycerides in Mice Fed a High-Fat Diet: Possible Role of Endocannabinoids , 2012, PloS one.

[12]  P. Elliott,et al.  Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human , 2012, Nature.

[13]  D. Mozaffarian,et al.  Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. , 2011, Journal of the American College of Cardiology.

[14]  K. Massey,et al.  High Pancreatic n-3 Fatty Acids Prevent STZ-Induced Diabetes in Fat-1 Mice: Inflammatory Pathway Inhibition , 2011, Diabetes.

[15]  M. Bohlooly-y,et al.  Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. , 2011, American journal of physiology. Endocrinology and metabolism.

[16]  R. Taguchi,et al.  Transgenic Restoration of Long-Chain n-3 Fatty Acids in Insulin Target Tissues Improves Resolution Capacity and Alleviates Obesity-Linked Inflammation and Insulin Resistance in High-Fat–Fed Mice , 2010, Diabetes.

[17]  S. Watkins,et al.  GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects , 2010, Cell.

[18]  N. Moniri,et al.  Agonism with the omega-3 fatty acids alpha-linolenic acid and docosahexaenoic acid mediates phosphorylation of both the short and long isoforms of the human GPR120 receptor. , 2010, Biochemical and biophysical research communications.

[19]  P. Pérez-Martínez,et al.  n-3 PUFA and lipotoxicity. , 2010, Biochimica et biophysica acta.

[20]  A. Butler,et al.  A Recurring Problem With the Analysis of Energy Expenditure in Genetic Models Expressing Lean and Obese Phenotypes , 2010, Diabetes.

[21]  V. Arroyo,et al.  Obesity‐induced insulin resistance and hepatic steatosis are alleviated by ω‐3 fatty acids: a role for resolvins and protectins , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  T. Doetschman Influence of genetic background on genetically engineered mouse phenotypes. , 2009, Methods in molecular biology.

[23]  Takafumi Hara,et al.  Distribution and regulation of protein expression of the free fatty acid receptor GPR120 , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[24]  H. Sone,et al.  Palmitate Impairs and Eicosapentaenoate Restores Insulin Secretion Through Regulation of SREBP-1c in Pancreatic Islets , 2008, Diabetes.

[25]  M. Bohlooly-y,et al.  Opposing Effects of Adiponectin Receptors 1 and 2 on Energy Metabolism , 2007, Diabetes.

[26]  M. Bohlooly-y,et al.  Phenotypic screening of hepatocyte nuclear factor (HNF) 4-γ receptor knockout mice , 2006 .

[27]  M. Bohlooly-y,et al.  G protein-coupled receptor 12 deficiency results in dyslipidemia and obesity in mice. , 2006, Biochemical and biophysical research communications.

[28]  W. Waldhäusl,et al.  Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n−3 polyunsaturated fatty acids , 2006, Diabetologia.

[29]  W. Malaisse,et al.  n-3 fatty acids and the metabolic syndrome. , 2006, The American journal of clinical nutrition.

[30]  J. Schölmerich,et al.  Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. , 2006, Journal of molecular endocrinology.

[31]  M. Bohlooly-y,et al.  Melanin-concentrating hormone receptor 1 deficiency increases insulin sensitivity in obese leptin-deficient mice without affecting body weight. , 2006, Diabetes.

[32]  M. Bohlooly-y,et al.  Phenotypic screening of hepatocyte nuclear factor (HNF) 4-gamma receptor knockout mice. , 2006, Biochemical and biophysical research communications.

[33]  A. J. Hulbert,et al.  Dietary fats and membrane function: implications for metabolism and disease , 2005, Biological reviews of the Cambridge Philosophical Society.

[34]  G. Tsujimoto,et al.  Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 , 2005, Nature Medicine.

[35]  L. Storlien,et al.  Role of fat amount and type in ameliorating diet‐induced obesity: insights at the level of hypothalamic arcuate nucleus leptin receptor, neuropeptide Y and pro‐opiomelanocortin mRNA expression , 2004, Diabetes, obesity & metabolism.

[36]  Yu Wang,et al.  The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. , 2003, The Journal of clinical investigation.

[37]  J. Chambers,et al.  The Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids* , 2003, The Journal of Biological Chemistry.

[38]  Masataka Harada,et al.  Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40 , 2003, Nature.

[39]  J. Crabtree,et al.  Bidirectional transcriptional activity of PGK‐neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice , 2001, Genesis.

[40]  P. Scherer,et al.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.

[41]  P. Ritz,et al.  Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults , 1997, International Journal of Obesity.

[42]  K. Herrup,et al.  Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. , 1995, Science.

[43]  A. J. Hulbert,et al.  Dietary fats, membrane phospholipids and obesity. , 1994, The Journal of nutrition.

[44]  E. Kraegen,et al.  Fish oil prevents insulin resistance induced by high-fat feeding in rats. , 1987, Science.